Bracco Features its Mission of 'No Compromise in MRI' at RSNA 2022
By MedImaging International staff writers Posted on 25 Nov 2022 |
Bracco Diagnostics Inc. (Monroe Township, N.J., USA), the US subsidiary of Bracco Imaging S.p.A., is featuring the recently FDA-approved Gadopiclenol Injection, a novel, highly stable macrocyclic gadolinium-based contrast agent (GBCA), commercialized as VUEWAY (gadopiclenol) injection by Bracco, among a robust line of imaging products, devices, and support solutions, at RSNA 2022.
Bracco is offering several engagement opportunities at RSNA 2022, including Meet and Connect with Peers during a media briefing that will profile 'No Compromise in Magnetic Resonance Imaging (MRI),' to summarize the company's comprehensive support and education, and spotlight the new category that VUEWAY injection creates for imaging agents. Bracco is also offering ‘Celebrate our Leaders on the Horizon’, an exclusive radiology residency program in which continuing education scholarships are awarded to five radiology residents whose submitted research papers are selected for publication in a special supplement to Applied Radiology. Visitors to the Bracco booth can experience its innovation throughout all diagnostic imaging modalities, including its Smartinject contrast delivery platforms, innovative informatics solutions, and best-in-class service offerings.
“We can think of no better venue to further educate and connect with our peers and industry partners than at RSNA, the world's largest medical imaging forum,” said Cosimo De Pinto, Senior Vice President, Sales and Marketing at Bracco Diagnostics Inc. “We've taken this year's congress theme of 'empowering patients and partners in our care' to heart, working hard to ensure our customers can look deeper and remain confident in the care they provide their patients. We are united in driving forward the next generation of diagnostic solutions as we unveil VUEWAY injection and work to fulfill our own mission of 'No Compromise in MRI'.”
Related Links:
Bracco Diagnostics Inc.
Latest RSNA 2022 News
- Hologic Showcases Comprehensive Breast and Skeletal Health Solutions at RSNA 2022
- Vieworks Exhibits Complete Lineup of Next Generation X-Ray Flat Panel Detectors at RSNA 2022
- Subtle Medical Showcases AI-Powered Imaging Workflow Solutions at RSNA 2022
- PaxeraHealth Demonstrates the Latest in Artificial Intelligence Technology for Imaging at RSNA 2022
- Varex Presents Advances in X-Ray Technology at RSNA 2022
- Radcal Demonstrates Accu-Gold TOUCH Series for X-Ray QA and Service at RSNA 2022
- Agfa Showcases Groundbreaking, Intelligent Solutions That Empower X-Ray Experts at RSNA 2022
- Philips Demonstrates Smart Connected Imaging and Integrated Workflow Solutions at RSNA 2022
- Bayer Highlights Radiology Portfolio and Innovation in AI at RSNA 2022
- Canon Showcases Meaningful Innovation in its Suite of Solutions and Products at RSNA 2022
- Mindray Debuts New Ultrasound Systems and Hepatology Solutions at RSNA 2022
- Siemens Presents Revolutionary High-End MRI Scanners at RSNA 2022
- 4DMedical Debuts Most Advanced Lung Scanning Technology in Decades at RSNA 2022
- KA Imaging Unveils World’s First Integrated Mobile X-Ray System with Dual-Energy Capabilities at RSNA 2022
- AIRS Medical Showcases Award-Winning MRI Enhancement AI Solution at RSNA 2022
- Alpinion Presents New Range of High-Performance Diagnostic Equipment at RSNA 2022